{
    "clinical_study": {
        "@rank": "95705", 
        "arm_group": [
            {
                "arm_group_label": "Dorsal Cheilectomy no Amniotic Membrane Tissue Implantation", 
                "arm_group_type": "Active Comparator", 
                "description": "Dorsal cheilectomy is a surgery for hallux rigidus(degenerative arthritis and stiffness due to bone spurs that affect the joint at the base of the big toe). No amniotic membrane will be used for this group."
            }, 
            {
                "arm_group_label": "Dorsal Cheilectomy-Amniotic Membrane Tissue Implantation", 
                "arm_group_type": "Experimental", 
                "description": "Dorsal cheilectomy procedure with the addition of the amniotic membrane. Amniotic membrane represents a biologic therapy that has the ability to actively regulate myrofibroblast formation and activity within the joint space and surgical site"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether patients undergoing a dorsal cheilectomy\n      procedure with implementation of amniotic membrane tissue results in improved clinical and\n      functional outcomes compared to a standard dorsal cheilectomy procedure.\n\n      Specific Aim 1:\n\n      To compare American Orthopedic Foot and Ankle Society (AOFAS) scores between patients\n      undergoing dorsal cheilectomy to patients undergoing dorsal cheilectomy with implantation of\n      amniotic membrane tissue.\n\n      Hypothesis 1: Clinical and functional outcomes, as measured by the AOFAS , in the patients\n      undergoing dorsal cheilectomy with implantation of amniotic membrane tissue will be superior\n      to those without.\n\n      Specific Aim 2:\n\n      To compare range of motion between patients undergoing dorsal cheilectomy to patients\n      undergoing dorsal cheilectomy with implantation of amniotic membrane tissue.\n\n      Hypothesis 2: Patient to undergo dorsal cheilectomy and implantation of amniotic membrane\n      tissue will demonstrate less postoperative stiffness as measured from the pre-and\n      postoperative radiographs.\n\n      Specific Aim 3:\n\n      To compare Foot Function Index (FFI) scores between patients undergoing dorsal cheilectomy\n      to patients undergoing dorsal cheilectomy with implantation of amniotic membrane tissue.\n\n      Hypothesis 3: Clinical and functional outcomes, as measured by the FFI, the patients\n      undergoing dorsal cheilectomy with implantation of amniotic membrane tissue will be superior\n      to those without."
        }, 
        "brief_title": "Amniotic Membrane as an Adjunct Treatment for Hallux Rigidus", 
        "completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Hallux Rigidus", 
        "condition_browse": {
            "mesh_term": [
                "Hallux Rigidus", 
                "Hallux Limitus"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients presented with an isolated diagnosis of type II hallux rigidus who are\n             candidates for operative management with dorsal cheilectomy.\n\n          -  Patients over the age of 18 able to consent to participate\n\n          -  The subject is psychosocially, mentally, and physically able to understand and comply\n             with the requirements of the study\n\n        Exclusion Criteria:\n\n          -  < 18 years of age\n\n          -  Patients that use ambulatory assistive devices\n\n          -  Patients with systemic inflammtory arthritis\n\n          -  Patient undergoing revision surgery for hallux rigidus to the ipsilateral extremity\n\n          -  Patients with significant arthritis requiring alternative surgery other than dorsal\n             cheilectomy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 2, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01825356", 
            "org_study_id": "03-13-03A"
        }, 
        "intervention": [
            {
                "arm_group_label": "Dorsal Cheilectomy no Amniotic Membrane Tissue Implantation", 
                "intervention_name": "Dorsal Cheilectomy without Amniotic Membrane Tissue Implantation", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Dorsal Cheilectomy-Amniotic Membrane Tissue Implantation", 
                "intervention_name": "Dorsal Cheilectomy with Amniotic Membrane Tissue Implantation", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "November 5, 2013", 
        "location": {
            "contact": {
                "email": "susan.odum@orthocarolina.com", 
                "last_name": "Susan M Odum, PhDc", 
                "phone": "704-323-2265"
            }, 
            "facility": {
                "address": {
                    "city": "Charlotte", 
                    "country": "United States", 
                    "state": "North Carolina", 
                    "zip": "28207"
                }, 
                "name": "OrthoCarolina"
            }, 
            "investigator": {
                "last_name": "John K Ellington, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "overall_contact": {
            "email": "susan.odum@orthocarolina.com", 
            "last_name": "Susan M Odum, PhDc", 
            "phone": "704-323-2265"
        }, 
        "overall_official": {
            "affiliation": "OrthoCarolina Research Institute, Inc.", 
            "last_name": "John K Ellington, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "American Orthopedic Foot and Ankle Society (AOFAS) score", 
            "safety_issue": "No", 
            "time_frame": "6 Months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01825356"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "OrthoCarolina Research Institute, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "OrthoCarolina Research Institute, Inc.", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}